Home
NewsNewsArbor Fertility™ with 8 locations in Missouri & Illinois has designed a streamlined patient-centred approach leading to Affordable, Accessible Fertility Care, making high-quality treatment available without financial burden.
In 2024, the fertility rate in the United States hit an all-time low of only 1.6 births per woman. The fertility rate has been going down steadily since 2007, and it is now well below the 2.1 births per woman needed to keep the population stable. Career development, education, and financial planning are important, but they don't fully explain the decline. At the same time, infertility is on the rise at an alarming rate, with an estimated 1 in 6 people around the world affected. This makes it much more common than most people think.
Arbor Fertility has eight locations in Missouri and Illinois, and they see how hard it is for people in those states to pay for expensive fertility treatments. The cost of one IVF cycle can be anywhere from $23,000 to $40,000. When Arbor Fertility™ was set up, the organisation's leaders knew that fertility care needed a new model that combined advanced reproductive medicine with a greater emphasis on cost and access. The clinic got ahead of the curve by designing a streamlined, patient-centred approach that made it easier and cheaper to get high-quality fertility care.
Apparently, the cost of an Arbor Fertility™ IVF cycle is less than $15,000. That plan has helped Arbor Fertility™ quickly become a leader in fertility care in the region. It shows that new treatments can work and be affordable at the same time. Dr. Shvetha Zarek, founder and medical director of Arbor Fertility™, says, “Our goal from the beginning was to build a practice that removes barriers, and the recent efforts to decrease the cost of fertility medications also support patients immensely.”
At Arbor Fertility™, one of the most important things they do towards taking a step toward Affordable, Accessible Fertility Care is use new technologies like ProteX™ semen collection systems for treatment and home collection semen analysis kits, as well as low-needle IVF medication protocols. According to Dr. Zarek, “These innovations allow us to improve both the clinical and patient experience with success at national standards. For far too long, the fertility experience for the male partner has been largely ignored. We are working to reverse this trend, with focused fertility treatments to improve testosterone levels and sperm parameters.”
Arbor Fertility™ is becoming a regional leader by offering lower prices and a hub-and-spoke model for its offices. This makes it easier for more couples to reach their goal of starting a family. Dr. Zarek says, "Our motto is Grow Your Family Tree™. “Children, parents, and grandparents are all welcome in our clinic, as supporting generational family growth is our calling.”
India's Central Drugs Standard Control Organisation has overhauled CDSCO IVF reagent sale norms, directing that all ART media, culture solutions, and reagents be supplied exclusively to clinics registered under the ART (Regulation) Act and Surrogacy (Regulation) Act. The move targets a growing unlicensed supply chain feeding an estimated 40–50% of India's 2,000-plus IVF centres.
Abu Dhabi University and FertiClinic Group have joined forces to establish the FertiClinic Reproductive Research Lab, an advanced reproductive research lab in Abu Dhabi housing IVF, andrology, and cryopreservation facilities. The partnership supports UAE national priorities, bridges academic and clinical expertise, and advances fertility innovation across the region.
NHS Kent and Medway has overhauled its fertility funding policy in a move that sees NHS cuts IVF access for thousands of patients. Effective 1 April 2026, the eligible age ceiling drops from 40 to 38, funded cycles fall from two to one, and embryo transfers are capped at two.
ASEAN's First Telemedicine IVF by Inspire IVF introduces a new era of remote fertility care. Combining AI technology with expert consultation, the platform enables global access, real-time monitoring, and personalised treatment planning, positioning Thailand as a leading hub for fertility services and advancing digital transformation in reproductive healthcare.
CSG.BIO has gone ahead with the acquisition of Hanabusa IVF, Asian Egg Bank, thereby making it a world leader in reproductive medicine and cutting-edge clinics with enhanced patient reach and advanced laboratory capabilities.
Wisconsin lawmakers from both parties are proposing bills to reduce IVF treatment costs. Republicans suggest a $5,000 tax credit for expenses, while Democrats want mandatory insurance coverage. With IVF cycles costing $20,000-$30,000 and 170,000 residents facing infertility, both parties seek affordable solutions through different approaches.
The AI-specialized Infertility Center, which is the largest in Asia, is open in Magok, Seoul and has begun its full-scale medical services from November 17 thereby marking the new era when it comes to fertility in the region.
